Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients-Reference-Cited by-同舟云学术

Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients

Published:2016 Issue:3 Volume:3 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Lehloenya Rannakoe J.¹²,Dlamini Sipho³,Muloiwa Rudzani⁴,Kakande Betty¹,Ngwanya Mzudumile R.¹,Todd Gail¹,Dheda Keertan²

Affiliation:

1. Division of Dermatology

2. Lung Infection and Immunity Unit

3. Division of Infectious Disease and HIV Medicine, Department of Medicine

4. Department of Paediatrics and Child Health, University of Cape Town, South Africa

Abstract

Abstract Elimination of a rifamycin from the treatment regimen for tuberculosis negatively impacts outcomes. Cross-reactivity between the rifamycins after drug eruptions is unclear. We report 6 consecutive human immunodeficiency virus-infected patients with rifampicin-associated drug rash with eosinophilia and systemic symptoms (DRESS) syndrome confirmed on diagnostic rechallenge. The patients subsequently tolerated rifabutin. These data inform clinical management of tuberculosis-associated drug reactions.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/3/3/ofw130/33622045/ofw130.pdf

Reference17 articles.

1. Tuberculosis;Dheda;Lancet,2016

2. Global tuberculosis report 2015: World Health Organization;World Health Organization,2015

3. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future;Lehloenya;Expert Rev Anti Infect Ther,2012

4. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking;Walsh;Clin Exp Dermatol,2011

5. Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions;Lehloenya;Int J Tuberc Lung Dis,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

2. Dermatology practice updates in mycobacterial disease;International Journal of Dermatology;2023-12-14

3. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses;Microorganisms;2023-01-30

4. Antituberculosis drug-induced non-blistering systemic severe reactions: A 10-year (2012-2022) literature review;Asian Pacific Journal of Allergy and Immunology;2023

5. New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug Reactions;The Journal of Allergy and Clinical Immunology: In Practice;2021-09